Evidence map›Paper›PMID 37967926›Full record

ArticleBMJ case reports2023

Treatment-induced neuropathy of diabetes: challenges in diagnosing neuropathic pain, value of sudomotor function testing.

Salim Abdelhamid, Majlinda Shabani, Arkadiusz Russjan, Alexander Andrea Tarnutzer

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Salim AbdelhamidInternal Medicine, Kantonsspital Baden AG, Baden, Switzerland.
Majlinda ShabaniInternal Medicine, Kantonsspital Baden AG, Baden, Switzerland.
Arkadiusz RussjanDepartment of Neurology and Neurorehabilitation, Zurzach Care AG, Bad Zurzach, Switzerland.
Alexander Andrea TarnutzerNeurology, Kantonsspital Baden AG, Baden, Switzerland alexander.tarnutzer@ksb.ch.ORCID http://orcid.org/0000-0002-6984-6958
Kantonsspital Baden · CHStiftung für Forschung in Spätantike und Mittelalter HR. Sennhauser · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A patient in his 60s was admitted for an extensive neurological work-up due to progressive asymmetrical, distally pronounced pain in both feet and legs. Conventional pain relievers did not help in pain reduction. A Sudoscan revealed small fibre damage in all extremities indicating an underlying neuropathy. The patient had started insulin treatment around 6 months prior to hospitalisation because of a newly diagnosed late-onset diabetes. Due to a rapid drop in glycated haemoglobin (from over 14% to 6% in 4 months), treatment-induced neuropathy of diabetes (TIND) was hypothesised. On increasing the dose of pregabalin and adding duloxetine, the patient reported improvement of symptoms, which further underlined the suspected diagnosis. Hence, in patients with severe hyperglycaemia, changes in glycaemic control should be stepwise and not rapid; however, to date, no guidelines exist how to avoid TIND.

Indexed as

Diabetes Mellitus, Type 2Diabetic NeuropathiesNeuralgiaAnalgesicsDuloxetine HydrochlorideHumansAnalgesicsDuloxetine HydrochlorideDiabetesNeuromuscular diseasePeripheral nerve disease

Identifiers

PMID37967926
PMCPMC10661014
OpenAlexW4388693696

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.